Conflict-of-interest by clinical investigators
This article was originally published in The Tan Sheet
Executive Summary
Will be the subject of a Sept. 9 meeting of FDA's Science Advisory Board at the request of FDA Commissioner David Kessler. The agency is currently working on a notice of proposed rulemaking on financial disclosure of clinical trial investigators that is slated for publication this fall. The science advisory board meeting will be held at the Ramada Inn in Bethesda, Md. beginning at 8:00 a.m. . . .